Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Mindfulness Training and Respiration Biosignal Feedback - Study 2

NCT07136948 · View on ClinicalTrials.gov ↗

Study Summary

The goal of this research is to test usability and user satisfaction with a new breathing feature on the meditation app, Equa, to help young adults who are distressed, understand their physiological responses and mindfulness skill development during meditation. Our main aims are to test an algorithm that can use physiologic signals to give feedback about how participant physiology is changing during guided lessons on the meditation app, Equa through: * Assessing user satisfaction and usability * Measuring how much participant mindfulness skills are improving Participants will: * Complete a survey about demographics, their thoughts and feelings before and after the mindfulness meditation program * Complete 14 smartphone guided mindfulness meditation training units while physiological measures are being recorded * A subset of participants will see a graph tracking their physiological responses from the guided meditation lesson and predictive mindfulness skill scores * Complete a few brief questionnaires before and after mindfulness practices to understand potential changes in their mindfulness skills

Interventions

  • BEHAVIORAL Mindfulness Meditation
  • BEHAVIORAL Mindfulness Meditation with Respiration Feedback Chart and Predictive Mindfulness Skill Scores

Study Locations (1)

Pennsylvania

  • GATF Building — Pittsburgh

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-07-21
Est. Completion 2025-11
Phase NA

Sponsor

Equa Health

1 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07136948

The ClinicalTrials.gov registry entry for NCT07136948 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Equa Health, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Psychological Distress appearing as the primary indexed condition, and to 2 interventions — of which Mindfulness Meditation is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT07136948 reports 1 study location spanning 1 distinct geographic area — top geographies include Pennsylvania. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT07136948 about?

NCT07136948 is a clinical study titled "Mindfulness Training and Respiration Biosignal Feedback - Study 2". The goal of this research is to test usability and user satisfaction with a new breathing feature on the meditation app, Equa, to help young adults who are distressed, understand their physiological responses and mindfulness skill development during meditation. Our main aims are to test an algorith...

What is the current status of trial NCT07136948?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-07-21. Estimated completion is 2025-11.

What conditions does trial NCT07136948 study?

This clinical trial studies the following conditions: Psychological Distress, Mindfulness Skills, Usability Satisfaction. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT07136948?

The interventions under investigation include: Mindfulness Meditation (BEHAVIORAL), Mindfulness Meditation with Respiration Feedback Chart and Predictive Mindfulness Skill Scores (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT07136948?

This trial is sponsored by Equa Health, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT07136948 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial